Nevired 200 Tablet contains Nevirapine 200mg, an established non-nucleoside reverse transcriptase inhibitor used as part of combination antiretroviral therapy for HIV infection. It helps in reducing viral replication and supports long-term immune system stability.
Nevirapine works by inhibiting the reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA and thereby reducing viral multiplication. This mechanism plays a key role in lowering viral load and improving CD4 cell counts when used in recommended treatment regimens.
For distributors and healthcare suppliers, Nevired 200 Tablet is a core antiretroviral medicine, routinely supplied to ART centers, hospitals, and government-supported HIV treatment programs. Consistent protocol-based prescribing ensures stable demand across healthcare institutions.
Adding Nevired 200 Tablet to your HIV and antiretroviral therapy segment creates strong opportunities in hospital supply, specialty pharmacies, export markets, and third-party manufacturing. Its proven clinical efficacy, global acceptance, and essential role in HIV management make it a valuable product in pharmaceutical distribution portfolios.